30 filings
8-K
AMLX
Amylyx Pharmaceuticals Inc
9 May 24
Amylyx Pharmaceuticals Reports First Quarter 2024 Financial Results
7:05am
8-K
AMLX
Amylyx Pharmaceuticals Inc
10 Apr 24
Other Events
9:19am
8-K
AMLX
Amylyx Pharmaceuticals Inc
4 Apr 24
Cost Associated with Exit or Disposal Activities
7:10am
8-K
AMLX
Amylyx Pharmaceuticals Inc
14 Mar 24
Departure of Directors or Certain Officers
9:18am
8-K
AMLX
Amylyx Pharmaceuticals Inc
8 Mar 24
Amylyx Pharmaceuticals Announces Topline Results From Global Phase 3 PHOENIX
7:10am
8-K
4q0wseyqrym0yy0sh3c
22 Feb 24
Amylyx Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results
7:08am
8-K
cs2m9qda208lfqbi96
7 Dec 23
Regulation FD Disclosure
7:00am
8-K
4uv zid4wusop
9 Nov 23
Amylyx Pharmaceuticals Reports Third Quarter 2023 Financial Results
6:58am
8-K
9ru8sl sgaj6kc8z8i
13 Oct 23
Other Events
5:20pm
8-K
f0t5cdu
10 Aug 23
Amylyx Pharmaceuticals Reports Second Quarter 2023 Financial Results
4:00pm
8-K
776j peba55jzyzp2
26 Jul 23
Other Events
4:36pm
8-K
ohf7kcu
23 Jun 23
Amylyx Pharmaceuticals Receives CHMP Negative Opinion on its Conditional Marketing Authorisation
5:16pm
8-K
2i0hd65p3 xc
9 Jun 23
Submission of Matters to a Vote of Security Holders
8:14am
8-K
i939sytq
11 May 23
Amylyx Pharmaceuticals Reports First Quarter 2023 Financial Results
4:00pm
8-K
vn8o27utcw14g
21 Mar 23
Departure of Directors or Certain Officers
4:51pm
8-K
pq47kjueyvv52vm p9p
13 Mar 23
Amylyx Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results
4:20pm
8-K
81ji9qgxt6qn6qtlq62a
14 Feb 23
Regulation FD Disclosure
6:30am
8-K
i5ykk8y9wkbw92p2fu5z
6 Dec 22
Entry into a Material Definitive Agreement
4:06pm
8-K
ljyca04c
10 Nov 22
Amylyx Pharmaceuticals Reports Third Quarter 2022 Financial Results
4:06pm
8-K
b58aqz1p33gzupca2kk5
2 Nov 22
Departure of Directors or Certain Officers
4:01pm